Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al.

Blanco R, González-López MA, González-Vela MC, Fernández-Llaca H, González-Gay MA.

Int J Dermatol. 2013 Mar;52(3):380-1. doi: 10.1111/j.1365-4632.2011.04949.x. No abstract available.

PMID:
23414167
2.

Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.

Harde V, Mrowietz U.

J Dtsch Dermatol Ges. 2009 Feb;7(2):139-41. doi: 10.1111/j.1610-0387.2008.06918.x. English, German.

PMID:
19371236
3.

Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.

Arenbergerova M, Gkalpakiotis S, Arenberger P.

Int J Dermatol. 2010 Dec;49(12):1445-9. doi: 10.1111/j.1365-4632.2010.04638.x.

PMID:
21091684
4.

A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa.

Amano M, Grant A, Kerdel FA.

Int J Dermatol. 2010 Aug;49(8):950-5. doi: 10.1111/j.1365-4632.2010.04545.x.

PMID:
21128923
5.

Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.

van Rappard DC, Leenarts MF, Meijerink-van 't Oost L, Mekkes JR.

J Dermatolog Treat. 2012 Aug;23(4):284-9. doi: 10.3109/09546634.2011.571657. Epub 2011 Jul 14.

PMID:
21756155
6.

Long-term successful adalimumab therapy in severe hidradenitis suppurativa.

Blanco R, Martínez-Taboada VM, Villa I, González-Vela MC, Fernández-Llaca H, Agudo M, González-López MA.

Arch Dermatol. 2009 May;145(5):580-4. doi: 10.1001/archdermatol.2009.49.

PMID:
19451504
7.

NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?

Ingram JR, Burton T.

Br J Dermatol. 2017 Feb;176(2):281-282. doi: 10.1111/bjd.15255. No abstract available.

PMID:
28244073
8.

Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.

Alzaga Fernandez AG, Demirci H, Darnley-Fisch DA, Steen DW.

Cornea. 2010 Oct;29(10):1189-91. doi: 10.1097/ICO.0b013e3181d4fd5c. Review.

PMID:
20628295
9.

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.

Miller I, Lynggaard CD, Lophaven S, Zachariae C, Dufour DN, Jemec GB.

Br J Dermatol. 2011 Aug;165(2):391-8. doi: 10.1111/j.1365-2133.2011.10339.x. Epub 2011 Jun 30.

PMID:
21457202
10.

Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.

Alecsandru D, Padilla B, Izquierdo JA, Fernández-Cruz E, Sánchez-Ramón S.

Arch Dermatol. 2010 Dec;146(12):1343-5. doi: 10.1001/archdermatol.2010.372. No abstract available.

PMID:
21173317
11.

[Hidradenitis suppurativa treated with infliximab].

Obadia DL, Daxbacher EL, Jeunon T, Gripp AC.

An Bras Dermatol. 2009 Nov-Dec;84(6):695-7. Portuguese.

12.

The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.

Moul DK, Korman NJ.

Arch Dermatol. 2006 Sep;142(9):1110-2. No abstract available.

PMID:
16982997
13.

Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.

[No authors listed]

Ann Intern Med. 2012 Dec 18;157(12):I-50. doi: 10.7326/0003-4819-157-12-201212180-00001. No abstract available.

PMID:
23247950
14.

New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.

van Rappard DC, Mooij JE, Baeten DL, Mekkes JR.

Br J Dermatol. 2011 Jul;165(1):194-8. doi: 10.1111/j.1365-2133.2011.10328.x.

PMID:
21428974
15.

Management of recalcitrant hidradenitis suppurativa with ustekinumab.

Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E.

Acta Derm Venereol. 2012 May;92(3):320-1. doi: 10.2340/00015555-1229. No abstract available.

16.

A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.

Koilakou S, Karapiperis D, Tzathas C.

Am J Gastroenterol. 2010 Jan;105(1):231-2. doi: 10.1038/ajg.2009.489. No abstract available.

PMID:
20054324
17.

Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.

Montes-Romero JA, Callejas-Rubio JL, Sánchez-Cano D, González-Martínez FJ, Navas-Parejo A, Ortego-Centeno N.

Eur J Intern Med. 2008 Oct;19(6):e32-3. doi: 10.1016/j.ejim.2007.11.014. Epub 2008 Mar 10. No abstract available.

PMID:
18848164
18.

Efficacy of adalimumab in recalcitrant hidradenitis suppurativa.

Sotiriou E, Apalla Z, Vakirlis E, Ioannides D.

Eur J Dermatol. 2009 Mar-Apr;19(2):180-1. doi: 10.1684/ejd.2008.0599. Epub 2009 Jan 20. No abstract available.

PMID:
19153066
19.

Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.

Rosi YL, Lowe L, Kang S.

J Dermatolog Treat. 2005 Feb;16(1):58-61.

PMID:
15897171
20.

Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.

Brunasso AM, Massone C.

Eur J Dermatol. 2010 Sep-Oct;20(5):644-6. doi: 10.1684/ejd.2010.1037. Epub 2010 Jul 9. No abstract available.

PMID:
20615818

Supplemental Content

Support Center